Skip to main content
Walvax Biotechnology Co.,Ltd. logo

Walvax Biotechnology Co.,Ltd. — Investor Relations & Filings

Ticker · 300142 ISIN · CNE100000WN2 LEI · 300300H82R2DIQXA8N24 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,790 across all filing types
Latest filing 2021-11-16 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300142

About Walvax Biotechnology Co.,Ltd.

https://www.walvax.com

Walvax Biotechnology Co.,Ltd. is a biopharmaceutical enterprise specializing in the research, development, production, and distribution of vaccines and other biological products. The company focuses on modern biotechnology to address public health challenges through a diverse portfolio of preventive vaccines. Key products include the 13-valent pneumococcal polysaccharide conjugate vaccine (PCV13), the bivalent human papillomavirus (HPV) vaccine, and various combination vaccines for meningitis and Haemophilus influenzae type b (Hib). Walvax operates advanced R&D platforms and manufacturing facilities that comply with international quality standards. The company is actively involved in the development of next-generation vaccine technologies, including mRNA and recombinant protein platforms, aiming to provide affordable and high-quality immunization solutions for global markets.

Recent filings

Filing Released Lang Actions
沃森生物：2021年第二次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, attendance, and voting procedures of the 2021 second extraordinary general meeting (临时股东大会) of Yunnan Watson Biotechnology Co., Ltd. It details the legality and compliance of the meeting process, the qualifications of attendees, and the voting results on various proposals. The document is not the meeting notice itself, nor is it the voting results announcement alone, but a legal opinion on the meeting's conduct and validity. This type of document is typically classified as a Declaration of Voting Results & Voting Rights Announcements (DVA) because it includes detailed voting results and legal validation of the shareholder meeting outcomes. The document length is 4208 characters, which is sufficient to contain substantive content rather than a brief announcement. Therefore, the best fit is DVA.
2021-11-16 Chinese
沃森生物：2021年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2021 second extraordinary general meeting of shareholders of Yunnan Watson Biotechnology Co., Ltd. It includes information about the meeting date, attendance, voting methods, voting results on various proposals, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on the official results of shareholder votes at a general meeting, including approval of audit firm reappointment, capital increase, and amendments to board rules. There is no financial data or report content, but rather the formal declaration of voting outcomes. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is 2705 characters, which is consistent with a detailed voting results announcement rather than a full report or presentation.
2021-11-16 Chinese
沃森生物：职工董事职工监事管理制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '云南沃森生物技术股份有限公司 职工董事职工监事管理制度' which translates to 'Yunnan Watson Biotechnology Co., Ltd. Employee Director and Employee Supervisor Management System.' It outlines the rules, responsibilities, nomination, election, rights, obligations, and management of employee directors and supervisors within the company. It references relevant laws and regulations but does not contain financial data, audit results, earnings, or any shareholder meeting materials. It is a governance-related internal regulation document about board and supervisory management practices rather than a report or announcement of financial or corporate events. Therefore, it fits best under Governance Information (CGR).
2021-11-16 Chinese
沃森生物：公司章程（2021年11月）
Governance Information Classification · 100% confidence The document is titled as the "Company Articles of Association" (公司章程) for 云南沃森生物技术股份有限公司 (Walvax Biotechnology Co., Ltd.). It contains detailed provisions on company organization, shareholder rights, board structure, share issuance, shareholder meetings, voting procedures, and other governance-related rules. There is no financial data, earnings information, or audit results presented. The content is focused on the internal rules and governance framework of the company. This matches the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2021-11-16 Chinese
关于召开2021年第二次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the convening of the 2021 second extraordinary general meeting (临时股东大会) of Yunnan Watson Biotechnology Co., Ltd. It includes information about the meeting date, voting procedures (both onsite and online), agenda items to be discussed and voted on (such as reappointment of the audit firm, capital increase, and amendments to board rules), registration details, and proxy authorization forms. The document does not contain any financial statements or results but serves as a notice and procedural guide for shareholders to participate in the meeting and vote on proposals. It is not a report of the meeting results nor a financial report. Given the detailed nature of the meeting notice and voting instructions, this fits the category of a Proxy Solicitation & Information Statement (PSI), which is used to provide shareholders with information and request votes for meetings.
2021-11-10 Chinese
关于修订《董事会议事规则》的公告
Governance Information Classification · 95% confidence The document is an announcement from Yunnan Watson Biotechnology Co., Ltd. regarding the revision of the "Board Meeting Rules" (董事会议事规则). It details specific changes to the rules governing the board of directors, including election procedures, meeting notifications, and the inclusion of employee representatives as directors. The document is a formal announcement of changes to governance rules rather than the rules themselves or a full governance report. It does not contain financial data, audit information, or meeting minutes but focuses on governance structure and procedures. Therefore, it fits best under the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 2828 characters, which is sufficient for a detailed governance announcement but not a full report like an annual report or interim report. Hence, the classification is CGR with high confidence.
2021-10-28 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.